Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031735 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Carmen Salguero-Aranda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biomedicina de Sevilla, Department of Pathology, Hospital Universitario Virgen del Rocío, CSIC-Universidad de Sevilla, 41013 Seville, Sp…. Hauptthemen laut MEDLINE: Neoplasms, Connective and Soft Tissue, Oncogene Proteins, Fusion, RNA-Binding Protein EWS, Soft Tissue Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grupo Español de Investigación en Sarcomas, Fundación Mari Paz Jiménez Casado (IV Beca Trienal FMPJC_GEIS 2020), Instituto de Salud Carlos III.
Abstract (Originalsprache)
Recurrent gene fusions (GFs) in translocated sarcomas are recognized as major oncogenic drivers of the disease, as well as diagnostic markers whose identification is necessary for differential diagnosis. EWSR1 is a ‘promiscuous’ gene that can fuse with many different partner genes, defining different entities among a broad range of mesenchymal neoplasms. Molecular testing of EWSR1 translocation traditionally relies on FISH assays with break-apart probes, which are unable to identify the fusion partner. Therefore, other ancillary molecular diagnostic modalities are being increasingly adopted for accurate classification of these neoplasms. Herein, we report three cases with rare GFs involving EWSR1 in undifferentiated mesenchymal neoplasms with uncertain differential diagnoses, using targeted RNA-seq and confirming with RT-PCR and Sanger sequencing. Two GFs involved hormone nuclear receptors as 3′ partners, NR4A2 and RORB, which have not been previously reported. NR4A2 may functionally replace NR4A3, the usual 3′ partner in extraskeletal myxoid chondrosarcoma. The third GF, EWSR1::BEND2, has previously been reported in a subtype of astroblastoma and other rare entities, including a single case of a soft-tissue tumor that we discuss in this work. In conclusion, our findings indicate that the catalogue of mesenchymal neoplasm-bearing EWSR1 fusions continues to grow, underscoring the value of using molecular ancillary techniques with higher diagnostic abilities in the routine clinical setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Biomedicina de Sevilla, Department of Pathology, Hospital Universitario Virgen del Rocío, CSIC-Universidad de Sevilla, 41013 Seville, Spain.
- Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III (CB16/12/00361; CIBERONC-ISCIII), 28029 Madrid, Spain.
- Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, 41004 Seville, Spain.
- Istituto Nazionale dei Tumori, Università degli Studi di Milano, 20133 Milan, Italy.
- Department of Pathology, Hospital Universitario Cruces, 48903 Barakaldo, Spain.
ORCID-Profile: Carmen Salguero-Aranda, Lourdes Galán, Laura Zaldumbide, Enrique de Álava, Juan Díaz-Martín
Förderung
- Grupo Español de Investigación en Sarcomas
- Fundación Mari Paz Jiménez Casado (IV Beca Trienal FMPJC_GEIS 2020)
- Instituto de Salud Carlos III
- Asociación Española Contra el Cáncer (Estudios Clínicos AECC 2022)
- Junta de Andalucía
- Asociación Pablo Ugarte
- Fundación María García Estrada
- Fundación CRIS contra el cáncer
Zitieren
APA
Salguero-Aranda, C., Di Blasi, E., Galán, L., Zaldumbide, L., Civantos, G., Marcilla, D., de Álava, E., & Díaz-Martín, J. (2024). Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031735
Vancouver
Salguero-Aranda C, Di Blasi E, Galán L, Zaldumbide L, Civantos G, Marcilla D, et al. Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031735
BibTeX
@article{SalgueroAranda2024,
author = {Salguero-Aranda, Carmen and Di Blasi, Elena and Galán, Lourdes and Zaldumbide, Laura and Civantos, Gema and Marcilla, David and de Álava, Enrique and Díaz-Martín, Juan},
title = {Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031735}
}
EUVIMED